PHE screening team members and clinicians attended the ECC 2016 Conference in Liverpool
The conference was attended by more than 550 cytologists from around the world. It featured major sessions on HPV (human papilloma virus) primary screening and cervical screening. Several speakers discussed the scientific and logistical aspects of implementing HPV primary screening.
Public Health England and NHS England have an HPV implementation group and are developing plans for national rollout of HPV as a primary test for cervical screening. Dr Anne Mackie, PHE’s Director of Screening, told the conference that a full options appraisal has been commissioned. Experts, including key opinion leaders in the relevant clinical fields, will contribute extensively to this. The options appraisal will look, in particular, at commissioning and laboratory configuration issues.